Novavax, Inc. (NVAX)
10.32
+0.20
(+1.93%)
USD |
NASDAQ |
Sep 02, 16:00
10.32
0.00 (0.00%)
After-Hours: 20:00
Novavax Cash and Short Term Investments (Quarterly) : 719.34M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 719.34M |
| March 31, 2026 | 790.33M |
| December 31, 2025 | 745.96M |
| September 30, 2025 | 773.71M |
| June 30, 2025 | 623.05M |
| March 31, 2025 | 742.16M |
| December 31, 2024 | 933.74M |
| September 30, 2024 | 920.08M |
| June 30, 2024 | 1.060B |
| March 31, 2024 | 491.04M |
| December 31, 2023 | 578.93M |
| September 30, 2023 | 661.50M |
| June 30, 2023 | 516.27M |
| March 31, 2023 | 635.28M |
| December 31, 2022 | 1.347B |
| September 30, 2022 | 1.291B |
| June 30, 2022 | 1.386B |
| March 31, 2022 | 1.582B |
| December 31, 2021 | 1.527B |
| September 30, 2021 | 1.945B |
| June 30, 2021 | 2.121B |
| March 31, 2021 | 2.030B |
| December 31, 2020 | 804.93M |
| September 30, 2020 | 571.18M |
| June 30, 2020 | 609.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 244.26M |
| December 31, 2019 | 81.77M |
| September 30, 2019 | 75.52M |
| June 30, 2019 | 77.02M |
| March 31, 2019 | 106.82M |
| December 31, 2018 | 102.98M |
| September 30, 2018 | 144.69M |
| June 30, 2018 | 177.24M |
| March 31, 2018 | 163.31M |
| December 31, 2017 | 185.54M |
| September 30, 2017 | 204.99M |
| June 30, 2017 | 217.50M |
| March 31, 2017 | 238.50M |
| December 31, 2016 | 265.79M |
| September 30, 2016 | 331.80M |
| June 30, 2016 | 399.67M |
| March 31, 2016 | 463.49M |
| December 31, 2015 | 265.62M |
| September 30, 2015 | 290.19M |
| June 30, 2015 | 314.94M |
| March 31, 2015 | 327.74M |
| December 31, 2014 | 168.35M |
| September 30, 2014 | 178.09M |
| June 30, 2014 | 152.66M |
| March 31, 2014 | 113.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.138B |
| Merck & Co., Inc. | 7.182B |
| Pfizer Inc. | 11.70B |
| Recursion Pharmaceuticals, Inc. | 551.07M |
| Agenus, Inc. | 18.74M |